Solicitation for Applications From Individuals Interested in Being Appointed to the Chronic Fatigue Syndrome Advisory Committee, 19205-19206 [2016-07593]

Download as PDF Federal Register / Vol. 81, No. 64 / Monday, April 4, 2016 / Notices 19205 TABLE 2—NEW ENTRIES TO THE LIST OF RECOGNIZED STANDARDS—Continued Recognition No. Title of standard 1 11–304 ............... Measuring Accuracy after Mechanical Disturbances. Reference No. and date ASTM F3107–14. K. Physical Medicine 16–196 ............... 16–197 ............... 16–198 ............... Wheelchairs—Part 7: Measurement of seating and wheel dimensions. Wheelchairs—Part 8: Requirements and test methods for static, impact, and fatigue strengths. Wheelchairs—Part 22: Set-up procedures .......... ISO 7176–7 First Edition 1998–05–15. ISO 7176–8 Second Edition 2014–12–15. ISO 7176–22 Second Edition 2014–09–01. L. Software/Informatics 13–81 ................. Health informatics—Personal health device communication—Part 10419: Device Specialization—Insulin Pump. IEEE Std. 11073–10419: 2015. M. Sterility 14–479 ............... Sterilization of health care products—Ethylene oxide—Requirements for development, validation, and routine control of a sterilization process for medical devices. ANSI/AAMI/ISO 11135:2014. N. Tissue Engineering 15–44 ................. 1 All Standard Guide for in vivo Evaluation of Osteoinductive Potential for Materials Containing Demineralized Bone (DBM) Active Standard. standard titles in this table conform to the style requirements of the respective organizations. IV. List of Recognized Standards mstockstill on DSK4VPTVN1PROD with NOTICES ASTM F2529–13. FDA maintains the Agency’s current list of FDA Recognized Consensus Standards in a searchable database that may be accessed directly at FDA’s Internet site at https://www.accessdata. fda.gov/scripts/cdrh/cfdocs/ cfStandards/search.cfm. FDA will incorporate the modifications and revisions described in this notice into the database and, upon publication in the Federal Register, this recognition of consensus standards will be effective. FDA will announce additional modifications and revisions to the list of recognized consensus standards, as needed, in the Federal Register, once a year or more often if necessary. Beginning with Recognition List: 033, FDA no longer announces minor revisions to the list of recognized consensus standards such as technical contact person, devices affected, processes affected, Code of Federal Regulations citations, and product codes. V. Recommendation of Standards for Recognition by FDA Any person may recommend consensus standards as candidates for recognition under section 514 of the FD&C Act by submitting such VerDate Sep<11>2014 19:03 Apr 01, 2016 Jkt 238001 recommendations, with reasons for the recommendation, to standards@ cdrh.fda.gov. To be properly considered, such recommendations should contain, at a minimum, the following information: (1) Title of the standard, (2) any reference number and date, (3) name and address of the national or international standards development organization, (4) a proposed list of devices for which a declaration of conformity to this standard should routinely apply, and (5) a brief identification of the testing or performance or other characteristics of the device(s) that would be addressed by a declaration of conformity. VI. Electronic Access You may obtain a copy of ‘‘Guidance on the Recognition and Use of Consensus Standards’’ by using the Internet. The Center for Devices and Radiological Health (CDRH) maintains a site on the Internet for easy access to information including text, graphics, and files that you may download to a personal computer with access to the Internet. Updated on a regular basis, the CDRH home page, https://www.fda.gov/ MedicalDevices, includes a link to standards-related documents including the guidance and the current list of recognized standards. After publication PO 00000 Frm 00094 Fmt 4703 Sfmt 4703 in the Federal Register, this notice announcing ‘‘Modification to the List of Recognized Standards, Recognition List Number: 041’’ will be available at https:// www.fda.gov/MedicalDevices/ DeviceRegulationandGuidance/ Standards/ucm123792.htm. You may access ‘‘Guidance on the Recognition and Use of Consensus Standards,’’ and the searchable database for ‘‘FDA Recognized Consensus Standards,’’ at https://www.fda.gov/MedicalDevices/ DeviceRegulationandGuidance/ Standards. Dated: March 29, 2016. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2016–07467 Filed 4–1–16; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Solicitation for Applications From Individuals Interested in Being Appointed to the Chronic Fatigue Syndrome Advisory Committee Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. AGENCY: E:\FR\FM\04APN1.SGM 04APN1 19206 mstockstill on DSK4VPTVN1PROD with NOTICES ACTION: Federal Register / Vol. 81, No. 64 / Monday, April 4, 2016 / Notices Notice. Authority: 42 U.S.C. 217a, section 222 of the Public Health Service (PHS) Act, as amended. The Committee is governed by the provisions of Public Law 92–463, as amended (5 U.S.C. App 2), which sets forth standards for the formation and use of advisory committees. SUMMARY: The Office of the Assistant Secretary for Health (OASH), within the Department of Health and Human Services (HHS), is seeking nominations of qualified candidates to be considered for appointment as a member of the Chronic Fatigue Syndrome Advisory Committee (CFSAC). CFSAC provides advice and recommendations to the Secretary of HHS, through the Assistant Secretary for Health (ASH), on a broad range of issues and topics related to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The appointments of several Committee members are scheduled to end during the 2016 calendar year. Nominations of qualified candidates are being sought to fill the positions that are scheduled to be vacated. DATES: Applications for individuals to be considered for appointment to the Committee must be received no later than 5 p.m. ET on April 25, 2016 at the address listed below. ADDRESSES: All nominations should be mailed or delivered to Nancy C. Lee, Designated Federal Officer, Chronic Fatigue Syndrome Advisory Committee, Office on Women’s Health, Office of the Assistant Secretary for Health, Department of Health and Human Services, 200 Independence Avenue SW., Room 712E, Washington, DC 20201. Nomination materials, including attachments, may be submitted electronically to cfsac@hhs.gov . FOR FURTHER INFORMATION CONTACT: Nancy C. Lee, Designated Federal Officer, Chronic Fatigue Syndrome Advisory Committee, Office on Women’s Health, Office of the Assistant Secretary for Health, Department of Health and Human Services, 200 Independence Ave. SW., Room 712E, Washington, DC 20201. Inquiries may also be made to cfsac@hhs.gov. SUPPLEMENTARY INFORMATION: CFSAC was established on September 5, 2002. The purpose of the CFSAC is to provide advice and recommendations to the Secretary of HHS, through the ASH, on issues related to ME/CFS. CFSAC advises and makes recommendations on a broad range of topics including: (1) The current state of knowledge and research; the relevant gaps in knowledge and research about the epidemiology, etiologies, biomarkers, and risk factors VerDate Sep<11>2014 19:03 Apr 01, 2016 Jkt 238001 relating to ME/CFS; and identifying potential opportunities in these areas; (2) impact and implications of current and proposed diagnostic and treatment methods for ME/CFS; (3) development and implementation of programs to inform the public, health care professionals, and the biomedical, academic, and research communities about ME/CFS advances; and (4) strategies to improve the quality of life of ME/CFS patients. The CFSAC charter is available at https://www.hhs.gov/ advcomcfs/charter/. Management and support services for Committee activities are provided by staff within the OASH. The ASH provides directions and guidance for services performed to support CFSAC activities and operation. Nominations: OASH is requesting nominations to fill CFSAC positions that are scheduled to be vacated during 2016. The Committee composition consists of seven scientists with demonstrated expertise in biomedical research applicable to ME/CFS, and four individuals with demonstrated expertise in health care delivery, private health care services, or insurance, or voluntary organizations concerned with the problems of individuals living with ME/ CFS. The vacant positions are in the biomedical research, health care services and delivery categories. Individuals selected for appointment to the Committee will serve as voting members and may be invited to serve terms of up to four years. To qualify for consideration of appointment to the Committee, an individual must possess demonstrated experience and knowledge in the designated fields or disciplines, as well as expert knowledge of the broad issues and topics pertinent to ME/CFS. CFSAC members are authorized to receive a stipend for attending Committee meetings. Committee members also are authorized to receive per diem and reimbursement for travel expenses incurred for conducting Committee business. Nomination materials should be typewritten. If mailed, please submit original documents. The nomination materials should be submitted (postmarked or received) no later than 5:00p.m. EDT on the date specified under DATES. The following information must be part of the nomination package submitted for each individual being nominated: (1) A letter of nomination that clearly states the name and affiliation of the nominee, the basis for the nomination (i.e., specific attributes which qualify the nominee for service in this capacity), and a statement that the nominee is willing to serve as a member PO 00000 Frm 00095 Fmt 4703 Sfmt 9990 of the Committee; (2) the nominator’s name, address, and daytime telephone number; (3) the home and/or work address, telephone number, and email address of the individual being nominated; and (4) a current copy of the nominee’s curriculum vitae or resume. An individual may self-nominate. Federal employees should not be nominated for consideration of appointment to this Committee. Nominations that do not contain all the above information will not be considered. Electronic submissions: Nomination materials, including attachments, may be submitted electronically to cfsac@ hhs.gov. Telephone and facsimile submissions cannot be accepted. Regular, Express, or Overnight Mail: Written documents may be submitted to the following addressee only: Nancy C. Lee, Designated Federal Officer, CFSAC, Office on Women’s Health, Office of the Assistant Secretary for Health, Department of Health and Human Services, 200 Independence Ave. SW., Room 712E, Washington, DC 20201. Appointment to the Committee is made by the Secretary of HHS. The Department makes every effort to ensure that the membership of federal advisory committees is fairly balanced in terms of points of view represented. Every effort is made to ensure that a broad representation of geographic areas, females, ethnic and minority groups, and people with disabilities are given consideration for membership on federal advisory committees. Appointment to this Committee shall be made without discrimination on the basis of age, race, ethnicity, gender, sexual orientation, disability, and cultural, religious, or socioeconomic status. Nominations must state that the nominee is willing to serve as a member of CFSAC and appears to have no conflict of interest that would preclude membership. Potential candidates are required to provide detailed information concerning such matters as financial holdings, consultancies, and research grants or contracts for an ethics analysis to be conducted to identify potential conflicts of interest. Dated: March 25, 2016. Nancy C. Lee, Designated Federal Officer. Chronic Fatigue Syndrome Advisory Committee [FR Doc. 2016–07593 Filed 4–1–16; 8:45 am] BILLING CODE 4150–42–P E:\FR\FM\04APN1.SGM 04APN1

Agencies

[Federal Register Volume 81, Number 64 (Monday, April 4, 2016)]
[Notices]
[Pages 19205-19206]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-07593]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Solicitation for Applications From Individuals Interested in 
Being Appointed to the Chronic Fatigue Syndrome Advisory Committee

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

[[Page 19206]]


ACTION: Notice.

-----------------------------------------------------------------------

    Authority: 42 U.S.C. 217a, section 222 of the Public Health Service 
(PHS) Act, as amended. The Committee is governed by the provisions of 
Public Law 92-463, as amended (5 U.S.C. App 2), which sets forth 
standards for the formation and use of advisory committees.

SUMMARY: The Office of the Assistant Secretary for Health (OASH), 
within the Department of Health and Human Services (HHS), is seeking 
nominations of qualified candidates to be considered for appointment as 
a member of the Chronic Fatigue Syndrome Advisory Committee (CFSAC). 
CFSAC provides advice and recommendations to the Secretary of HHS, 
through the Assistant Secretary for Health (ASH), on a broad range of 
issues and topics related to myalgic encephalomyelitis/chronic fatigue 
syndrome (ME/CFS). The appointments of several Committee members are 
scheduled to end during the 2016 calendar year. Nominations of 
qualified candidates are being sought to fill the positions that are 
scheduled to be vacated.

DATES: Applications for individuals to be considered for appointment to 
the Committee must be received no later than 5 p.m. ET on April 25, 
2016 at the address listed below.

ADDRESSES: All nominations should be mailed or delivered to Nancy C. 
Lee, Designated Federal Officer, Chronic Fatigue Syndrome Advisory 
Committee, Office on Women's Health, Office of the Assistant Secretary 
for Health, Department of Health and Human Services, 200 Independence 
Avenue SW., Room 712E, Washington, DC 20201. Nomination materials, 
including attachments, may be submitted electronically to cfsac@hhs.gov 
.

FOR FURTHER INFORMATION CONTACT: Nancy C. Lee, Designated Federal 
Officer, Chronic Fatigue Syndrome Advisory Committee, Office on Women's 
Health, Office of the Assistant Secretary for Health, Department of 
Health and Human Services, 200 Independence Ave. SW., Room 712E, 
Washington, DC 20201. Inquiries may also be made to cfsac@hhs.gov.

SUPPLEMENTARY INFORMATION: CFSAC was established on September 5, 2002. 
The purpose of the CFSAC is to provide advice and recommendations to 
the Secretary of HHS, through the ASH, on issues related to ME/CFS. 
CFSAC advises and makes recommendations on a broad range of topics 
including: (1) The current state of knowledge and research; the 
relevant gaps in knowledge and research about the epidemiology, 
etiologies, biomarkers, and risk factors relating to ME/CFS; and 
identifying potential opportunities in these areas; (2) impact and 
implications of current and proposed diagnostic and treatment methods 
for ME/CFS; (3) development and implementation of programs to inform 
the public, health care professionals, and the biomedical, academic, 
and research communities about ME/CFS advances; and (4) strategies to 
improve the quality of life of ME/CFS patients. The CFSAC charter is 
available at https://www.hhs.gov/advcomcfs/charter/.
    Management and support services for Committee activities are 
provided by staff within the OASH. The ASH provides directions and 
guidance for services performed to support CFSAC activities and 
operation.
    Nominations: OASH is requesting nominations to fill CFSAC positions 
that are scheduled to be vacated during 2016. The Committee composition 
consists of seven scientists with demonstrated expertise in biomedical 
research applicable to ME/CFS, and four individuals with demonstrated 
expertise in health care delivery, private health care services, or 
insurance, or voluntary organizations concerned with the problems of 
individuals living with ME/CFS. The vacant positions are in the 
biomedical research, health care services and delivery categories.
    Individuals selected for appointment to the Committee will serve as 
voting members and may be invited to serve terms of up to four years.
    To qualify for consideration of appointment to the Committee, an 
individual must possess demonstrated experience and knowledge in the 
designated fields or disciplines, as well as expert knowledge of the 
broad issues and topics pertinent to ME/CFS.
    CFSAC members are authorized to receive a stipend for attending 
Committee meetings. Committee members also are authorized to receive 
per diem and reimbursement for travel expenses incurred for conducting 
Committee business.
    Nomination materials should be typewritten. If mailed, please 
submit original documents. The nomination materials should be submitted 
(postmarked or received) no later than 5:00p.m. EDT on the date 
specified under DATES. The following information must be part of the 
nomination package submitted for each individual being nominated: (1) A 
letter of nomination that clearly states the name and affiliation of 
the nominee, the basis for the nomination (i.e., specific attributes 
which qualify the nominee for service in this capacity), and a 
statement that the nominee is willing to serve as a member of the 
Committee; (2) the nominator's name, address, and daytime telephone 
number; (3) the home and/or work address, telephone number, and email 
address of the individual being nominated; and (4) a current copy of 
the nominee's curriculum vitae or resume. An individual may self-
nominate. Federal employees should not be nominated for consideration 
of appointment to this Committee. Nominations that do not contain all 
the above information will not be considered.
    Electronic submissions: Nomination materials, including 
attachments, may be submitted electronically to cfsac@hhs.gov.
    Telephone and facsimile submissions cannot be accepted.
    Regular, Express, or Overnight Mail: Written documents may be 
submitted to the following addressee only: Nancy C. Lee, Designated 
Federal Officer, CFSAC, Office on Women's Health, Office of the 
Assistant Secretary for Health, Department of Health and Human 
Services, 200 Independence Ave. SW., Room 712E, Washington, DC 20201.
    Appointment to the Committee is made by the Secretary of HHS. The 
Department makes every effort to ensure that the membership of federal 
advisory committees is fairly balanced in terms of points of view 
represented. Every effort is made to ensure that a broad representation 
of geographic areas, females, ethnic and minority groups, and people 
with disabilities are given consideration for membership on federal 
advisory committees. Appointment to this Committee shall be made 
without discrimination on the basis of age, race, ethnicity, gender, 
sexual orientation, disability, and cultural, religious, or 
socioeconomic status. Nominations must state that the nominee is 
willing to serve as a member of CFSAC and appears to have no conflict 
of interest that would preclude membership. Potential candidates are 
required to provide detailed information concerning such matters as 
financial holdings, consultancies, and research grants or contracts for 
an ethics analysis to be conducted to identify potential conflicts of 
interest.

    Dated: March 25, 2016.
Nancy C. Lee,
Designated Federal Officer. Chronic Fatigue Syndrome Advisory Committee
[FR Doc. 2016-07593 Filed 4-1-16; 8:45 am]
 BILLING CODE 4150-42-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.